Hyderabad Study Exposes Critical Late Detection in Male Breast Cancer Cases
A comprehensive six-year medical investigation conducted in Hyderabad has uncovered a deeply concerning pattern in the diagnosis of male breast cancer within the city. The research reveals that one in every four male patients is diagnosed only when the disease has progressed to stage IV, the most advanced and severe stage. This finding underscores a significant public health challenge related to delayed detection and diagnosis.
Study Details and Alarming Statistics
The pivotal study was carried out at the ESIC Medical College and Hospital located in Sanathnagar, spanning from 2019 to 2025. Its findings were formally published in the esteemed Journal of the Association of Physicians of India (JAPI). The research involved a detailed analysis of 15 male breast cancer patients, providing critical insights into their diagnostic journeys.
The data presents a stark picture: 60% of these patients first presented at stage III, while 26.7% were already at stage IV upon their initial consultation. This means that nearly 87% of the men in the study had advanced cancer when they first sought medical attention, highlighting a severe gap in early detection.
The Problem of Diagnostic Inertia and Delayed Care
Medical professionals involved in the study have identified diagnostic inertia as a primary culprit behind these late diagnoses. This term refers to the frequent overlooking or misinterpretation of breast cancer symptoms in men during the early, more treatable stages of the disease.
Doctors documented an average delay of six months between the initial appearance of symptoms and a confirmed diagnosis. The most commonly reported symptom was a noticeable lump behind the nipple, often accompanied by other changes such as nipple retraction or skin thickening. In two severe cases, patients presented with ulcerated tumours, a clear indicator of disease progression exacerbated by delayed medical intervention.
Dr. Gumdal Vishesh, Head of the Department of Medical and Hemato Oncology at ESIC Medical College, provided crucial context. "None of the patients in our study had a family history of breast cancer or known risk factors like hormone exposure, radiation, or occupational hazards. While breast cancer is rare in men, its symptoms are frequently ignored or misinterpreted by both patients and healthcare providers," he explained. "It is imperative that men experiencing such symptoms seek early medical evaluation. Furthermore, those diagnosed should undergo genetic testing to check for inherited mutations that could inform treatment."
Treatment Outcomes and Barriers to Care
By the 2025 follow-up, the study reported that nine patients (60%) were alive with their disease under control. The breakdown of their status was as follows:
- Five patients had successfully completed their prescribed treatment.
- Two patients were continuing with hormone therapy.
- Two patients with stage IV cancer had achieved stable disease.
However, the outcomes were not uniformly positive. Tragically, two patients succumbed to disease progression, and four patients (26.7%) discontinued their follow-up appointments, raising concerns about long-term management.
Dr. Vishesh highlighted significant non-medical barriers affecting patient care. "Despite the availability of free treatment at ESIC facilities, many patients face obstacles such as long travel distances, a lack of social or familial support, the stigma associated with a 'female' cancer, and critically low awareness about male breast cancer. These factors collectively hinder care-seeking behavior," he added.
Broader Implications and Calls for Action
Although male breast cancer constitutes less than 1% of all breast cancer cases globally, the consequences of delayed detection are severe, drastically impacting survival rates and quality of life. The study also brought to light the absence of male-specific clinical guidelines for breast cancer screening and diagnosis.
Dr. Nivalika Rajamoni, a Senior Oncologist at Yashoda Hospitals, emphasized the urgent need for targeted awareness. "There is a critical and immediate requirement for public health campaigns specifically focused on men. Male breast cancer is conspicuously absent from most health messaging, leading to dangerous gaps in knowledge and early action," she stated.
Experts also commented on systemic improvements. They noted that the recent decision by the Telangana government to classify cancer as a notifiable disease is a positive step that will enhance data collection and monitoring. However, they unanimously called for the establishment of national-level cancer registries and the development of tailored policy interventions to address the unique challenges of male breast cancer diagnosis and treatment across India.
